Pfizer Launches Trial to Evaluate COVID-19 Vaccine in Pregnant Women

Pfizer Launches Trial to Evaluate COVID-19 Vaccine in Pregnant Women
A health worker administers a dose of the Pfizer-BioNtech COVID-19 vaccine to a pregnant woman at Clalit Health Services, in Israel's Mediterranean coastal city of Tel Aviv on Jan. 23, 2021. Jack Guez/AFP via Getty Images
Zachary Stieber
Updated:

Pfizer and its partner company said this week that they’re launching a clinical trial to see if their COVID-19 vaccine is safe and effective for pregnant women.

The phase 2/3 study will test approximately 4,000 healthy, pregnant women 18 years of age or older, according to Pfizer and BioNTech. The women will get the shot between 24 to 34 weeks of gestation in the randomized, placebo-controlled, observer-blind trial.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics